𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Isolation and identification of adenovirus from conjunctival scrapings over a two-year period (between 2001 and 2003) in Yokohama, Japan

✍ Scribed by Kiyohiko Matsui; Sukumar Saha; Masaaki Saitoh; Nobuhisa Mizuki; Norihiko Itoh; Eiichi Okada; Atsushi Yoshida; Ke-Qin Xin; Osamu Nishio; Kenji Okuda


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
130 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Over a 2‐year period between 2001 and 2003, a total of 115 conjunctival scrapings were collected from patients with keratoconjuctivitis from several hospitals in Yokohama, Japan. Out of 115, 94 (82.4%) cases of adenoviruses were detected by polymerase chain reaction (PCR); 60 (52.1%) by cell culture isolation; and 16 (14.0%) by enzyme‐linked immunosorbent assay (ELISA). The serotypes were determined by PCR‐ restriction fragment length polymorphism analysis (PCR‐RFLP) and by the neutralization test (NT). PCR‐RFLP was performed using a combination of endonucleases such as __Hha__I, __Alu__I, and __Hae__III. Of the 94 PCR‐positive samples, the serotypes of 91 (96.8%) were identified by PCR‐RFLP analysis (adenovirus 3: 50%, 4: 11%, and 8: 32%). Out of the 115 samples, 60 samples were identified by the neutralization (adenovirus 3, 4, 7, and 8). When both PCR‐RFLP and the neutralization techniques were used, 53.2%, 11.7%, 1.1%, and 34% of the samples were identified as adenovirus 3, 4, 7, and 8, respectively. In contrast to the results of a nationwide surveillance report, adenovirus 3 was found as a major cause of keratoconjunctivitis in the Yokohama area. The nationwide surveillance report did not reflect accurately the epidemiological situation in the local area. In order to obtain surveillance data that would be useful for the prevention of an adenovirus conjunctivitis epidemic, it seems that local epidemiology is more important than that nationwide surveillance. J. Med. Virol. 79:200–205, 2007. © 2006 Wiley‐Liss, Inc.